We are analyzing https://link.springer.com/chapter/10.1007/978-3-030-32656-2_9.

Title:
The Bone Microenvironment in Prostate Cancer Metastasis | SpringerLink
Description:
The propensity of prostate cancer cells to seed the skeleton and then progress into clinically relevant metastatic tumors is widely recognized and a major cause of morbidity and mortality for patients. The natural history of prostate adenocarcinoma most frequently...
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Health & Fitness
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't see how the site brings in money.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

pubmed, google, scholar, cancer, article, cas, prostate, bone, central, cell, metastasis, cells, metastatic, res, metastases, receptor, chapter, rev, nat, stem, tumor, patients, nature, niche, clin, carcinoma, med, growth, fatatis, androgen, hematopoietic, urol, dormancy, mol, mechanisms, molecular, differentiation, oncol, neuroendocrine, medicine, progression, breast, biol, skeletal, treatment, privacy, cookies, content, information, publish,

Topics {✒️}

pubmed google scholar month download article/chapter targeting tumor–stromal interactions extracellular signal-regulated kinase platelet-derived growth factor multi-functional complex organ parathyroid hormone-related protein castration-resistant prostate cancer tartrate-resistant acid phosphatase small-cell carcinoma features ct-guided bone biopsies hormone-sensitive prostate cancer human hematopoietic stem pain-related neurochemical reorganization stem cell quiescence bone-metastatic prostate cancer pre-clinical mouse models gas6 receptor status androgen receptor signaling chemokine receptor cx3cr1 privacy choices/manage cookies human prostate cancer small cell carcinoma bone-metastasis-free survival osteoblastic cells regulate stem cell niche device instant download prostate cancer stem bone cell interactions cancer stem cells osteoblastic metastatic lesions metastatic prostate cancer metastatic prostate cancer editor information editors cell-autonomous features placebo-controlled trial subclonal metastatic expansion prostate cancer cells treat metastatic cancer prostate-specific antigen bone metastatic niche masonic cancer center advanced prostate cancer stage simultaneously presents neuroendocrine prostate cancer cell-autonomous driving cxcr4 antagonist circulating tumour cells cancer cells cooperate chapter dinatale

Questions {❓}

Farach-Carson, Prostate cancer and neuroendocrine differentiation: more neuronal, less endocrine?
Poupon, A ‘class action’ against the microenvironment: do cancer cells cooperate in metastasis?

Schema {🗺️}

ScholarlyArticle:
      headline:The Bone Microenvironment in Prostate Cancer Metastasis
      pageEnd:184
      pageStart:171
      image:https://media.springernature.com/w153/springer-static/cover/book/978-3-030-32656-2.jpg
      genre:
         Biomedical and Life Sciences
         Biomedical and Life Sciences (R0)
      isPartOf:
         name:Prostate Cancer
         isbn:
            978-3-030-32656-2
            978-3-030-32655-5
         type:Book
      publisher:
         name:Springer International Publishing
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Anthony DiNatale
            affiliation:
                  name:Drexel University College of Medicine
                  address:
                     name:Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, USA
                     type:PostalAddress
                  type:Organization
                  name:Thomas Jefferson University
                  address:
                     name:Program in Prostate Cancer, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Alessandro Fatatis
            affiliation:
                  name:Drexel University College of Medicine
                  address:
                     name:Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, USA
                     type:PostalAddress
                  type:Organization
                  name:Thomas Jefferson University
                  address:
                     name:Program in Prostate Cancer, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      keywords:
      description:The propensity of prostate cancer cells to seed the skeleton and then progress into clinically relevant metastatic tumors is widely recognized and a major cause of morbidity and mortality for patients. The natural history of prostate adenocarcinoma most frequently begins with a tumor diagnosed at a localized stage, which is successfully treated by surgical and/or radiation therapy modalities. A relevant percentage of patients are clinically cured but approximately 20–30% will develop biochemical signs of recurrence, which respond to the inhibition of androgen receptor (AR) signaling by hormone-deprivation and receptor antagonists, before the inevitable transition into castration-resistant prostate cancer (CRPC). This stage simultaneously presents with or is rapidly followed by secondary tumors, which involve the skeleton in more than 90% of cases (mCRPC). While generalization in clinical practice is always unwise, it is indisputable that bone-metastatic prostate cancer is virtually incurable. Decades of research have revealed that the tissue microenvironment provided by the bone marrow is as important as the cell-autonomous features of tumor cells in fostering the right conditions that lead to establishment and progression of metastatic tumors in the skeleton.
      datePublished:2019
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
      context:https://schema.org
Book:
      name:Prostate Cancer
      isbn:
         978-3-030-32656-2
         978-3-030-32655-5
Organization:
      name:Springer International Publishing
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Drexel University College of Medicine
      address:
         name:Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, USA
         type:PostalAddress
      name:Thomas Jefferson University
      address:
         name:Program in Prostate Cancer, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, USA
         type:PostalAddress
      name:Drexel University College of Medicine
      address:
         name:Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, USA
         type:PostalAddress
      name:Thomas Jefferson University
      address:
         name:Program in Prostate Cancer, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Anthony DiNatale
      affiliation:
            name:Drexel University College of Medicine
            address:
               name:Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, USA
               type:PostalAddress
            type:Organization
            name:Thomas Jefferson University
            address:
               name:Program in Prostate Cancer, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, USA
               type:PostalAddress
            type:Organization
      name:Alessandro Fatatis
      affiliation:
            name:Drexel University College of Medicine
            address:
               name:Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, USA
               type:PostalAddress
            type:Organization
            name:Thomas Jefferson University
            address:
               name:Program in Prostate Cancer, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, USA
      name:Program in Prostate Cancer, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, USA
      name:Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, USA
      name:Program in Prostate Cancer, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(431)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js

CDN Services {📦}

Pbgrd

4.45s.

LINK . SPRINGER . COM {}